Skip to content

MEDLAP

Active
Private limited companyfounded 20251 yr activeRue des Arts 36, 1400 Nivelles, BelgiumKBO/BCE: BE 1023.567.556
Summary

The computed 12-month bankruptcy probability of MEDLAP is 1.9% (moderate). The 2025 annual accounts show equity of €22,166 and a net result of €19,999. The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability100
Solvency97
Growth-
Track record67
Bankruptcy probability, 12 months
1.9% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,500 at 30 days acceptable
Liquidity ample (current ratio 6.02; short-term debt: 16.3% and cash: 2% of total assets), and 28.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
71.9%
Return on assets
64.9%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-09-2026, 55 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
55 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 21 May 2025, MEDLAP was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€22,166
Total assets
€30,811
Net result
€19,999
Working capital
€25,207

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €30,811
Fixed assets €580
Current assets €30,231
Equity and liabilities €30,811
Equity €22,166
Debt €8,645
Debt finances 28.1% of the balance-sheet total.
Key figures and ratios
2025 value
Current ratio
6.02
Debt to equity
0.39
ROE
90.2%
ROA
64.9%
Debt ≤ 1 year
€5,023
Debt > 1 year
€580
Income taxes
€5,661

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 1.9% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 34 lines
Balance sheet Code2025
Assets
Total assets20/58€30,811
Fixed assets21/28€580
Financial fixed assets28€580
Current assets29/58€30,231
Amounts receivable within one year40/41€4,839
Other amounts receivable41€4,839
Cash at bank and in hand54/58€619
Deferred charges and accrued income490/1€24,773
Equity and liabilities
Total equity and liabilities10/49€30,811
Equity10/15€22,166
Contributions10/11€3,000
Profit (loss) carried forward14€19,166
Amounts payable17/49€8,645
Amounts payable after more than one year17€580
Other amounts payable178/9€580
Amounts payable within one year42/48€5,023
Trade debts44€1,074
Suppliers440/4€1,074
Taxes, remuneration and social security45€1,106
Taxes450/3€1,106
Other amounts payable47/48€2,844
Accrued charges and deferred income492/3€3,041
Income statement Code2025
Other operating charges640/8€635
Gross operating margin9900€26,488
Operating profit (loss)9901€25,853
Financial charges65/66B€193
Recurring financial charges65€193
Profit (loss) for the period before taxes9903€25,660
Income taxes67/77€5,661
Profit (loss) for the period9904€19,999
Profit (loss) for the period to be appropriated9905€19,999
Appropriation of the result
Profit (loss) to be appropriated9906€19,999
Profit to be distributed694/7€833
Return on contributions (dividend)694€833

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Other operating charges640/8€635
Gross operating margin9900€26,488
Operating profit (loss)9901€25,853
Financial charges65/66B€193
Recurring financial charges65€193
Profit (loss) for the period before taxes9903€25,660
Income taxes67/77€5,661
Profit (loss) for the period9904€19,999
Profit (loss) for the period to be appropriated9905€19,999
Line2025
Assets
Total assets20/58€30,811
Fixed assets21/28€580
Financial fixed assets28€580
Current assets29/58€30,231
Amounts receivable within one year40/41€4,839
Other amounts receivable41€4,839
Cash at bank and in hand54/58€619
Deferred charges and accrued income490/1€24,773
Equity and liabilities
Total equity and liabilities10/49€30,811
Equity10/15€22,166
Contributions10/11€3,000
Profit (loss) carried forward14€19,166
Amounts payable17/49€8,645
Amounts payable after more than one year17€580
Other amounts payable178/9€580
Amounts payable within one year42/48€5,023
Trade debts44€1,074
Suppliers440/4€1,074
Taxes, remuneration and social security45€1,106
Taxes450/3€1,106
Other amounts payable47/48€2,844
Accrued charges and deferred income492/3€3,041
Line2025
Profit (loss) for the period9904€19,999
Operating cash flow (approximation)€19,999

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
24-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 55 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nivelles · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
142 m²
Building footprint
145 m²
Volume, LiDAR
737 m³
Parcel 25072B0290/00Z006, Wallonia · tallest building 6.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEDLAP
Rue des Arts 36, 1400 NivellesGeneral medical practice
since 20252.374.065.102
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25072B0290/00Z006 Wallonia 142 m² 1 · 145 m² 6.6 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded21-05-2025
Fiscal year end31-12
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.